HIF on why voluntary licensing of patents is not required
In book on the Health Impact Fund,* Aidan Hollis and Thomas Pogge discuss why voluntary licensing of patents is not required.
Page 22
Voluntary Licensing
In book on the Health Impact Fund,* Aidan Hollis and Thomas Pogge discuss why voluntary licensing of patents is not required.
Page 22
Voluntary Licensing
KEI will later issue a more detailed comment on the Health Impact Fund. One of the key issues that will be addressed is the way that Hollis and Pogge propose turning the prize fund proposals that are based upon open licensing of patents into something that reinforces the monopoly supply chain.
We understand that one motivation for doing this was to attract support from some large pharmaceutical companies, and the European governments that protect them.
WHO has announced the names for the Expert Working Group on R&D financing
We don’t know everyone on the list, but for the people that we do know, we are generally impressed. The WHO seems to have created a body with considerable expertise and reputation, and included people who will consider new ideas. This seems like a very good start.
Below is the final agreed upon text for the SCCR 17 on the issue of access for persons with reading disabilities. There are four sentences, in one paragraph.
The representative from the government of Chile (on behalf of Chile, Nicaragua, Brazil and Uruguay) delivered this very powerful statement this afternoon at WIPO during the Seventeenth Session of the Standing Committee on Copyright and Related Rights (SCCR).
Chile proposed that the WIPO secretariat distributes a questionnaire on copyright exceptions and limitations between all WIPO Member States in order to continue with the information gathering process. Chile remarked on the good experience with the APEC survey on exceptions and limitations.
KEI has filed comments on the EC’s Green Paper on Copyright in the Knowledge Economy. Here are pdf and odt copies. The html version follows below. Comments of Knowledge Ecology International (KEI) on the GREEN PAPER: Copyright in the Knowledge… Continue Reading
I’m in Geneva at WIPO for the 17th SCCR meeting. The first two days have presentations of four WIPO studies of copyright limitations and exceptions. Each study gets a half day. The first presentation was by Sam Ricketson.
WIPO Study on Limitations and Exceptions of Copyright and Related Rights in the Digital Environment, (SCCR/9/7), April 5, 2003. prepared by Mr. Sam Ricketson, Professor of Law, University of Melbourne and Barrister, Victoria, Australia
The Ricketson presentation was very clear.
I have been asked to elaborate on the relationship between the Medical Innovation Prize Fund (S.2210, 110th Congress) and the WTO TRIPS Agreement.
For centuries, innovation inducement prizes have been suggested as a mechanism to stimulate investments in a wide range of topics. (See, for example, Selected Innovation Prizes and Reward Programs, KEI Research Note 2008:1). During most of this period, the patent system has also existed.
According to a note sent to KEI, CNIB in Canada considers the WBU proposal for a WIPO Treaty for the reading disabled to be “the most critical component of achieving true equality through the development of a ‘Global Library’!. This is a letter that Jim Sanders, the President and Chief Executive Officer of CNIB, sent to the Canada delegation to WIPO.
According to the WSJ today PhRMA is spending $13.2 million in an “ad buy to prop up 28 Congressional candidates, many of them vulnerable and all but three of them Democrats.” The Journal points out